Applied Genetic Technologies Corp has reached its limit for free report views.
Applied Genetic Technologies Corp does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops gene therapy products for inherited orphan ophthalmology diseases in the United States. The company’s lead product candidates in the preclinical stage comprise treatments for X-linked retinoschisis, Congenital Achromatopsia, and X-linked retinitis pigmentosa, which are diseases of the eye caused by mutations in single genes.
